Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |